References and Notes
1
Vine KL.
Locke JM.
Ranson M.
Pyne SG.
Bremner JB.
J. Med. Chem.
2007,
50:
5109
2a
Verma M.
Pandeya SN.
Singh KN.
Stables JP.
Acta Pharm.
2004,
54:
49
2b
Bhattacharya SK.
Chakrabarti A.
Ind.
J. Exp. Biol.
1998,
36:
118
2c
Pajouhesh H.
Parson R.
Popp FD.
J.
Pharm. Sci.
1983,
72:
318
3 Kitaura Y, Ito F, Stevens RW, and Asai N. inventors; US Patent, US 4835166.
; Chem. Abstr. 1989, 112, 35864t
4a
Varma RS.
Nobles WL.
J. Pharm. Sci.
1975,
64:
881
4b
Gil-Turnes MS.
Hay ME.
Fenical W.
Science
1989,
246:
116
4c
Fatima I.
Ahmad I.
Anis I.
Malik A.
Afza N.
Molecules
2007,
12:
155
5a
Maysinger D.
Movrin M.
Arzneim.-Forsch.
1980,
30:
1839
5b
Movrin M.
Medić-Sarić M.
Eur.
J. Med. Chem.
1978,
13:
309
6
Da Silva JFM.
Garden SJ.
Pinto AC.
J. Braz. Chem. Soc.
2001,
12:
273
7
Sassatelli M.
Debiton E.
Aboab B.
Prudhomme M.
Moreau P.
Eur.
J. Med Chem.
2006,
41:
709
8
Kawasaki T.
Nagaoka M.
Satoh T.
Okamoto A.
Ukon TR.
Ogawa A.
Tetrahedron
2004,
60:
3493
9a
Sandmeyer T.
Helv. Chim. Acta
1919,
2:
234
9b
Marvel CS.
Hiers GS.
Org.
Synth.
1941,
1:
327
10a
Noland WE.
Rieke RD.
J. Org. Chem.
1962,
27:
2250
10b
Sassatelli M.
Saab E.
Anizan F.
Prudhomme M.
Moreau P.
Tetrahedron
Lett.
2004,
45:
4827
11
Parrick J.
Yahya A.
Ijaz AS.
Yizun J.
J. Chem. Soc., Perkin Trans.
1
1989,
2009
12
Tatsugi J.
Zhiwei T.
Izawa Y.
ARKIVOC
2001,
(i):
67
13
Yadav JS.
Reddy BVS.
Reddy CS.
Krishna AD.
Synthesis
2007,
693
14
Yadav JS.
Reddy BVS.
Reddy CS.
Krishna AD.
Tetrahedron
Lett.
2007,
48:
2029
15
Piancatelli G.
Scettri A.
D’Auria M.
Synthesis
1982,
245
16a
Srinivas C.
Kumar CNSSP.
Rao VJ.
Palaniappan S.
J. Mol. Catal. A: Chem.
2007,
265:
227
16b
Srinivas U.
Srinivas C.
Narender P.
Rao VJ.
Palaniappan S.
Catal.
Commun.
2007,
8:
107
17
Palaniappan S.
Lakshmi Devi S.
Polymer Degrad.
Stabil.
2006,
91:
2415
18
Representative
Experimental Procedure: In a typical experiment, PCC (2.5 mmol,
537 mg) was added to a solution of indole (1 mmol, 117 mg) in 1,2-DCE
(5 mL). Polyaniline salt catalyst [15 wt% with
respect to indole (17 mg)] was added and the reaction mixture
was stirred at r.t. or at reflux. Completion of the reaction was
monitored by TLC. After completion, the reaction mixture was filtered
through a Celite® pad and washed with EtOAc
(2 × 5 mL). The combined organic extracts were dried and
evaporated under vacuum. The crude product was purified by silica
gel column chromatography (n-hexane-EtOAc,
3:1) to furnish isatin (129 mg, 88%). A similar procedure
was adopted for the preparation of other isatins, 3-hydroxy oxindoles
and the authenticity of the products was confirmed from their ¹H NMR
and mass spectral data.
19
Spectral Data
for New Compounds:
1-Butyl-5-chloroindoline-2,3-dione
(Table 2, entry 8): TLC: R
f
0.5 (30% EtOAc-hexanes);
orange solid; mp 62-63 ˚C. IR (KBr): 3089, 2953,
1737, 1606, 1448, 1339, 1185, 1116, 844, 720 cm-¹. ¹H
NMR (200 MHz, CDCl3): δ = 7.49 (m, J = 8.1 Hz, 2 H), 6.80 (d, J = 8.1 Hz, 1 H), 3.70 (t, J = 7.3 Hz, 2 H), 1.67 (quint, J = 7.3 Hz, 2 H), 1.43 (m, J = 7.3 Hz, 2 H), 0.98 (t, J = 7.3 Hz, 3 H). ¹³C
NMR (200 MHz, CDCl3): δ = 182.5, 157.6,
149.4, 137.5, 129.3, 125.1, 118.3, 111.8, 40.07, 29.08, 20.0, 13.5.
MS (ESI): m/z = 238 [M + H+].
HRMS (ESI): m/z [M + H+] calcd
for C12H13NClO2: 238.0634; found
238.0630.
1-Methyl-5-nitroindoline-2,3-dione
(Table 2, entry 9): TLC: R
f
0.3 (50% EtOAc-hexanes);
yellowish orange solid; mp 203 ˚C. IR (KBr): 2924, 1743,
1610, 1465, 1331, 1289, 1109, 1074, 845, 747, 710, 600 cm-¹. ¹H
NMR (200 MHz, CDCl3): δ = 8.47 (dd, J = 8.8 Hz, 1 H), 8.34 (d, 1
H), 7.06 (d, J = 8.8 Hz, 1 H),
3.29 (s, 3 H). ¹³C NMR (200 MHz, CDCl3): δ = 182.1,
157.3, 150.3, 140.5, 128.0, 118.3, 116.7, 111.5, 26.2. GC-MS: m/z = 206 [M+].
Anal. Calcd for C9H6N2O4: C,
52.44; H, 2.93; N, 13.59. Found: C, 52.40; H, 2.78; N, 13.42.
1-Octyl-1
H
-pyrrolo[2,3-
b
]pyridine-2,3-dione (Table 2, entry
15): TLC: R
f
0.5
(30% EtOAc-hexanes); yellow solid; mp 74-76 ˚C.
IR (KBr): 3063, 2925, 2855, 1737, 1592, 1456, 1353, 1263, 1085,
783, 738 cm-¹. ¹H
NMR (200 MHz, CDCl3): δ = 8.41 (d,
1 H), 7.78 (d, 1 H), 7.05 (t, 1 H), 3.83 (t, 2 H), 1.74 (t, 2 H),
1.25-1.35 (m, 10 H), 0.87 (t, 3 H). ¹³C NMR
(200 MHz, CDCl3): δ = 180.9, 163.3,
157.3, 154.9, 131.8, 118.1, 110.9, 38.9, 30.7, 28.6, 28.1, 26.5,
25.8, 21.6, 13.03. MS (ESI): m/z = 261 [M + H+].
HRMS (ESI): m/z [M + H+] calcd
for C15H21N2O2: 261.1603;
found: 261.1606.